# Azulfidine EN-tabs

NDC: 0013-0102
Generic name: Sulfasalazine
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 19500620

FDA application: NDA007073

## Active ingredients

- SULFASALAZINE: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0013-0102"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0013-0102
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b9ef541a-93c8-4428-ba45-398aa0b327d1